People at risk of a cardiac event after a percutaneous coronary intervention (PCI) stent procedure who received long-term antiplatelet therapy with clopidogrel were 29% less likely to die than those ...

"Clopidogrel might be an attractive alternative to aspirin with a borderline ischemic benefit beyond 1 year after PCI," the authors wrote. "This important study confirms that ischemic protection ...

A study suggests that a certain type of blood thinner may be more effective than aspirin in preventing heart attacks and strokes in patients with a specific form of heart disease. The research also ...